Timm, J., Bateson, A., Solanki, P., Paleckyte, A., Witney, A. A., Rofael, S. A. D., . . . Sun, E. (2023). Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid. PLOS global public health, 3(10), e0002283. https://doi.org/10.1371/journal.pgph.0002283
Chicago Style (17th ed.) CitationTimm, Juliano, et al. "Baseline and Acquired Resistance to Bedaquiline, Linezolid and Pretomanid, and Impact on Treatment Outcomes in Four Tuberculosis Clinical Trials Containing Pretomanid." PLOS Global Public Health 3, no. 10 (2023): e0002283. https://doi.org/10.1371/journal.pgph.0002283.
MLA (9th ed.) CitationTimm, Juliano, et al. "Baseline and Acquired Resistance to Bedaquiline, Linezolid and Pretomanid, and Impact on Treatment Outcomes in Four Tuberculosis Clinical Trials Containing Pretomanid." PLOS Global Public Health, vol. 3, no. 10, 2023, p. e0002283, https://doi.org/10.1371/journal.pgph.0002283.